Notícias e Atividades da Bicycle Therapeutics
Presença
Sede: Estados Unidos
Bicycle Therapeutics é uma empresa listada sob o símbolo BCYC (US).
Executivos
Veja o organograma con seus 28 executivos principais
Biografias mais buscadas da Bicycle Therapeutics
- Kevin Lee, Chief Executive Officer and Director
- Jose-Carlos Gutierrez, Director
- Stephen Sands, Director
Recentes movimentos de executivos em Bicycle Therapeutics
- Michael Skynner antes Chief Technology Officer, foi promovido a Chief Scientific Officer (Notícia publicada em 3 de fevereiro de 2026).
- Michael Method antes Senior Vice President, Clinical Development, foi promovido a Chief Medical Officer (Notícia publicada em 3 de fevereiro de 2026).
Criar um alerta
para seguir os movimentos de executivos da Bicycle Therapeutics.
Biotecnologia
Bicycle Therapeutics possui 2.430 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).
Popular M&A news in Biotecnologia
- Tempus has announced the acquisition of Personalis (publicado em 20 de julho de 2026).
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Bicycle Therapeutics
- Press Releases | Bicycle Therapeutics
- Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update | Bicycle Therapeutics
- Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry | Bicycle Therapeutics
- Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration | Bicycle Therapeutics
- Bicycle Therapeutics Announces First Patient Dosed in Expansion Cohorts of Phase I/II Trial of Bicycle® Toxin Conjugate BT5528 in Patients with Advanced Solid Tumors Associated with EphA2 Expression | Bicycle Therapeutics
- Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference | Bicycle Therapeutics
- Bicycle Therapeutics to Present Trials in Progress Poster Featuring BT7480 Phase I/II Clinical Trial at the 2022 ASCO Annual Meeting | Bicycle Therapeutics
- Bicycle Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update | Bicycle Therapeutics
- Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting | Bicycle Therapeutics
- Bicycle Therapeutics to Present Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting | Bicycle Therapeutics
- View more press releases Close
Redes sociais sobre Bicycle Therapeutics
- Bicycle Therapeutics na Wikipedia, Google News e Yahoo Finance
- Bicycle Therapeutics na LinkedIn, X (Twitter) e YouTube
